Clark D. West, … , Janice M. McConville, Neil C. Davis
Citation Information: J Clin Invest. 1967;46(4):539-548. https://doi.org/10.1172/JCI105555.
Clark D. West, … , Janice M. McConville, Neil C. Davis
Published April 1, 1967
Citation Information: J Clin Invest. 1967;46(4):539-548. https://doi.org/10.1172/JCI105555.
Abstract
Evidence has been obtained for the presence in vivo of alpha2D-globulin, a breakdown product of serum β1C-globulin, in patients with acute and persistent hypocomplementemic glomerulonephritis. The protein has been identified by immunoelectrophoretic analysis, and the amounts present have been determined by direct measurement of specific antigenic determinants present on alpha2D. β1A-Globulin, another breakdown product of β1C-globulin, may also be present in vivo in severely hypocomplementemic patients, but its levels are much lower than those of alpha2D-globulin.
Authors
Clark D. West, Sara Winter, Judith Forristal, Janice M. McConville, Neil C. Davis
Full Text PDF | Download (2.14 MB)
Copyright © 2022 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)